Seth Klarman (Baupost Group) exit Theravance Biopharma, Inc.
Seth Klarman (Baupost Group) exit $-35.6K of disclosed value in Theravance Biopharma, Inc..
Signal
Investor Move
Action
Exit
Capital
$-35.6K disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.